Faculty Articles

Distinct MAP Kinase Activation Patterns of Angiotensin and Cannabinoid Systems in SHR Astrocytes

Publication Title

The FASEB Journal

Publisher

Federation of American Societies for Experimental Biology (FASEB)

ISSN

1530-6860

Publication Date

4-2017

Keywords

angiotensin, astrocytes, cannabinoid systems, kinkase, Spontaneously Hypertensive Rats (SHRs)

Abstract

Abstract

Objective

To determine the effect of exogenous Angiotensin (Ang) II and ACEA, both alone and in combination, on MAP kinase activation in astrocytes isolated from Spontaneously Hypertensive Rats (SHRs) and Wistar rats.

Background

By activation of astroglial Ang type 1 receptor (AT1R) and Cannabinoid type 1 receptor (CB1R), Ang II and cannabinoids are able to exert potent effects on proliferation and neuroinflammation. An increase in phosphorylation states of MAP kinases such as ERK and p38, has been linked to several functions in astrocytes. Although crosstalk between the two receptors has been reported by us and several other groups, the consequences of this interaction at the level of MAP kinase activation has not been investigated.

Methods

Astrocytes were isolated from the brainstem and cerebellum of Spontaneously Hypertensive Rats (SHR) and normotensive Wistar rats. The cells were treated with 100 nM Ang II or 10 nM ACEA, both alone and in combination, for varying time periods and the extent of phosphorylation was measured using Western blotting.

Results

Ang II treatment resulted in greater activation of MAP kinases in brainstem astrocytes, but not cerebellar astrocytes, of SHRs when compared to Wistar rats. ACEA treatement on the other hand, is associated with a greater activation of MAP kinases in brainstem, but not cerebellar, astrocytes of Wistar rats when compared to SHRs. Co-treatment of Ang II and ACEA resulted in greater activation of ERK and p38, than Ang II or ACEA treatments alone, in brainstem astrocytes isolated from both SHRs and Wistar rats. In cerebellar astrocytes however, co-treatment did not result in greater activation of MAP kinases than the treatments alone in both rat models.

Conclusion

Greater MAP kinase activation, by ACEA, in brainstem astrocytes of Wistar rats when compared to SHRs is suggestive of a potential diminished endocannabinoid tone in pathological conditions such as hypertensions. An augmentation of MAP kinase activation by the combination treatment in brainstem astrocytes, but not cerebellar astrocytes, is indicative of a potential dampening of one system by the other in cerebellar astrocytes. Our findings suggest that the crosstalk between AT1R and CB1R may differ depending on the brain area and the underlying pathological condition.

Support or Funding Information

NSU HPD: Grant # 335585

Volume

31

Issue

1_Supplement

Disciplines

Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences

Link to Full Text
Peer Reviewed

Find in your library

Share

COinS